Clinical trials
Observational Parkinson Disease trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
61 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2009 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 6 |
| 2020 | 7 |
| 2021 | 6 |
| 2022 | 4 |
| 2023 | 8 |
| 2024 | 3 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 22 |
| Recruiting | 18 |
| Unknown status | 12 |
| Not yet recruiting | 4 |
| Terminated | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Exeter | 6 |
| Northumbria University | 4 |
| King's College London | 3 |
| South Glasgow University Hospitals NHS Trust | 3 |
| University of Oxford | 3 |
| Abbott Medical Devices | 2 |
| Boston Scientific Corporation | 2 |
| Newcastle-upon-Tyne Hospitals NHS Trust | 2 |
| Oxford Brookes University | 2 |
| University College, London | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Parkinson Disease | 61 |
| Neurodegenerative Diseases | 6 |
| Dystonia | 4 |
| Movement Disorders | 4 |
| Multiple Sclerosis | 4 |
| Pain | 4 |
| REM Sleep Behavior Disorder | 4 |
| Essential Tremor | 3 |
| Parkinsonian Disorders | 3 |
| Tremor | 3 |
Trials
Showing 1 to 25 of 61. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.